Crossmark

Early development of infants with neurofibromatosis type 1: a case series

Crossref DOI link: https://doi.org/10.1186/s13229-017-0178-0

Published Online: 2017-11-23

Published Print: 2017-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

,

Kolesnik, Anna May

Jones, Emily Jane Harrison

Garg, Shruti

Green, Jonathan

Charman, Tony

Johnson, Mark Henry
Funding

Funding for this research was provided by:

Action Medical Research (GN2385)

Medical Research Council (G0701484)

Autistica

FP7 Ideas: European Research Council (115300)

H2020 Excellent Science (642990)
License Information

Text and Data Mining valid from 2017-11-23
More Information

Article History

Received: 3 August 2017

Accepted: 31 October 2017

First Online: 23 November 2017

Ethics approval and consent to participate

: The study was approved by the NHS London Central and East of England Research Ethics Committees (16/EE/0167 and 06/MRE02/73); the parents of all the infant participants provided informed consent before the data collection began.

: Parents of infant participants consented to anonymised data being included in publications.

: The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.